TSX open
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • 200 free stock & ETF trades
  • Unlimited commission-free trades on 180+ select ETFs
  • Offer ends September 30, 2026
Stocks

Why Kits Eyecare Ltd stock is rising today

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:KITS.TO

Get KITS alerts:

Photos provided by Pexels

Kits Eyecare Ltd is making waves on the TSX with a notable 4.55% increase in stock price, reflecting strong investor confidence.

In the latest trading session, Kits Eyecare Ltd (KITS.TO) saw its stock price climb by 4.55%, closing at CA$14.71. This surge comes after impressive financial performance, showcasing the company's resilience and growth potential in the eyecare sector.

Advertisement

Kits Eyecare Ltd

KITS.TO

Full stock page →

KITS.TO

Kits Eyecare Ltd

Source:WealthAwesomeWealthAwesome
$5.25 (-27.70%)
120 day period
$10.84$15.18$19.52Feb 13May 12Aug 6

Market cap

$490.55M

P/E

144.3x

52W high

$22.56

52W low

$10.61

1W change

+5.06%

Beta

0.21

Analyst Price Targets

Based on analyst covering KITS

📈

Wall Street analysts forecast KITS stock price to rise 60.3% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$21.96

+60.3% Upside

Current Price

C$13.70

Last close

Compare analyst targets across the TSX & TSXV →

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on KITS's historical volatility

HistoricalForecast68%95%
C$9.15C$13.18C$17.21C$21.24C$25.27C$29.30TodayMar 30Jun 3Aug 6Sep 18Nov 1Dec 14

30-Day Vol

46.2%

Annualized

90-Day Vol

53.4%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$16.38

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$14.54C$12.40C$17.05
60 trading daysC$15.43C$12.32C$19.33
90 trading daysC$16.38C$12.43C$21.59

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Investor takeaway: Kits Eyecare's consistent revenue growth and expanding customer base position it favorably in the market, making it a stock to watch for Canadian investors interested in the healthcare sector.

Kits Eyecare Ltd's stock rises 4.55% in one day

With a market cap of CA$492.25 million, Kits Eyecare continues to show strong growth potential, especially after surpassing one million active customers.

Bull case

The company's recent financial results show a strong growth trajectory, with a 27% year-over-year increase in annual revenue, reaching CA$202.5 million. This marks the 13th consecutive quarter of positive adjusted EBITDA, highlighting the company's financial stability and growth path. Investors are responding positively to these results, which demonstrate the company's operational efficiency and market demand.

Bear case

Despite the positive performance, the high P/E ratio of 147.1 raises concerns that the stock may be overvalued. This could lead to volatility if growth expectations aren't met.

Advertisement

Strong Financial Performance

Kits Eyecare Ltd recently reported a remarkable 27% increase in annual revenue, reaching CA$202.5 million. This marks the 13th consecutive quarter of positive adjusted EBITDA, reinforcing the company's financial stability and growth trajectory. Investors are responding positively to these results, which underscore the company's operational efficiency and market demand.

Expanding Customer Base

The company has surpassed one million active customers, doubling its customer base since its IPO in 2021. This significant milestone not only reflects the brand's growing popularity but also indicates a strong market presence. With a solid customer foundation, Kits Eyecare is well-positioned to capitalize on future growth opportunities in the eyecare industry.


Advertisement

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: July 10, 2026
Last Updated: July 10, 2026

Sponsored links

Advertisement